NASDAQ · EXPO

Exponent Inc.

$62.76 +$1.32 (+2.15%) 1D After hours

Key Metrics

$2.98B
Market cap
27.36×
P/E · TTM
$602.81M
Revenue · TTM
$108.93M
Net income
EPS · TTM $2.11
Dividend yield 2.1%
Free cash flow $113.39M
Beta · 1Y 0.53
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 14
    From its Feb 6 high, the share price fell 33%.

    Peak close $79.79 on Feb 6; trough close $53.67 on May 14. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -33%
  • Feb 6
    The stock moved +12.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 6

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$2.98B
Enterprise value
Shares outstanding48.5M
52-wk range$51.91 – $81.95
Avg volume · 20D285.6K
Net cash
Book value / share$6.55
IndustryServices-Management Consulting Services
ExchangeNASDAQ
About Exponent Inc.
IPO dateApr 25, 1985
Employees1013

Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E27.36
P/S4.94
P/FCF26.29
EV/EBITDA
EV/Sales
Graham №$17.63

Profitability

Gross
Operating 25.2%
Net 18.1%
FCF 18.8%
ROE / ROIC 32.2% · 49.6%

Financial Health

Current ratio2.40
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital$198.69M

Cash Flow · TTM

Operating CF $123.48M
Capex −$10.09M
Free cash flow $113.39M
Buybacks $170.39M
Dividends paid $61.76M
Shareholder yield 7.8%

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

8.5
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$17.63 vs $62.76
Trades 3.6× above classic defensive value — priced for growth
Fundamentals through 2026-04-03 · computed by TickerWolf from SEC filings